Cost Plus Drugs Prescription Process: How It Works, What It Costs, and How It Compares

What Is the Cost Plus Drugs Prescription Process, Step by Step?

The prescription process at Cost Plus Drugs has four steps: obtain a valid prescription from a licensed U.S. Provider, create a free account at costplusdrugs.com, upload or transfer the prescription, and check out with a credit or debit card. The pharmacy does not offer telehealth services, so patients who lack a current prescription must see a separate provider first.

Step 1: Get a Valid Prescription

Cost Plus Drugs fills only Schedule V and non-controlled medications. Your prescribing physician, nurse practitioner, or physician assistant sends an electronic prescription directly to Cost Plus Drugs through most major e-prescribing platforms, or you can request a paper prescription and upload a photo during checkout.

The FDA requires all pharmacies dispensing prescription drugs to verify a valid prescriber-patient relationship before dispensing. [2] Cost Plus Drugs complies with this requirement through its dispensing partner Truepill, a licensed mail-order pharmacy operating under standard federal and state pharmacy law.

Step 2: Create an Account and Search the Formulary

Account creation requires a name, shipping address, date of birth, and email. Search the formulary before requesting your prescription be sent there. Not every drug is listed. As of early 2025, the formulary includes approximately 2,500 medications, weighted heavily toward generic versions of common chronic-disease drugs: statins, metformin, lisinopril, levothyroxine, amlodipine, and oncology generics such as imatinib and dasatinib.

Step 3: Transfer or Upload the Prescription

Electronic transfers arrive automatically when your provider selects Cost Plus Drugs in their e-prescribing software. Paper prescriptions require a photo upload. Cost Plus Drugs does not currently accept transfers from other retail pharmacies for controlled substances. For non-controlled medications, standard pharmacy-to-pharmacy transfer rules under state law apply. [3]

Step 4: Pay and Receive Delivery

All orders are cash pay. No insurance card is accepted. The pricing formula is public: manufacturer acquisition cost plus 15% markup, plus a $3 pharmacy fee, plus $5 flat-rate shipping. Delivery typically runs 5 to 7 business days via USPS or UPS. No same-day or next-day option exists, which matters for acute prescriptions.

Is Cost Plus Drugs Legit? Licensing and Regulatory Standing

Cost Plus Drugs is a legitimate, licensed pharmacy operation. Truepill, the fulfillment partner, holds pharmacy licenses in all 50 states and is registered with the DEA for non-controlled dispensing. The platform is also accredited through NABP (National Association of Boards of Pharmacy) .pharmacy domain standards, which require verified state licensure, a valid prescription requirement, and a licensed pharmacist on staff. [4]

The Transparent Pricing Model

The pricing model is the core differentiator. A 2021 analysis published in JAMA Internal Medicine found that list prices for 77 commonly prescribed generic drugs were substantially higher at traditional retail pharmacies than their actual acquisition costs, with markups sometimes exceeding 1,000% above manufacturer price. [1] Cost Plus Drugs addresses this by publishing its acquisition cost alongside the final price on every product page.

For imatinib 400 mg (30 tablets), the Cost Plus Drugs price has been listed at approximately $17, against a GoodRx coupon price of roughly $100 to $200 and a cash retail price of several thousand dollars. The difference is not marginal.

Who Owns Cost Plus Drugs?

Mark Cuban launched Cost Plus Drugs (formally Mark Cuban Cost Plus Drug Company, PBC) in January 2022 as a public benefit corporation. A public benefit corporation is legally required to consider public benefit alongside shareholder returns, which theoretically reduces incentive to maximize drug markups. [5] This legal structure does not replace FDA or state board oversight but adds an accountability layer that standard LLCs do not carry.

What the Research Says About Cash-Pay Pharmacies

A 2019 study in JAMA Internal Medicine (N=9,722 medication purchases) found that using a pharmacy discount program rather than insurance resulted in lower prices for 23% of the 80 most common generic drugs studied, with savings exceeding $10 per fill in many cases. [6] Cost Plus Drugs operates on a similar cash-pay principle but undercuts even most discount-program prices by eliminating the middleman margin entirely.

The Health Affairs journal reported in 2023 that pharmacy benefit manager (PBM) spread pricing added an estimated $1.3 billion annually to Medicaid drug costs alone. [7] Cost Plus Drugs bypasses PBMs entirely, which is a structural cost advantage, not merely a marketing claim.

What Does Cost Plus Drugs Actually Cost? Real Price Examples

Pricing is transparent and searchable without an account. The table below reflects prices publicly listed on the Cost Plus Drugs formulary in early 2025. Prices may change as manufacturer acquisition costs shift.

| Drug | Strength | Qty | CPD Price | Typical GoodRx Low | Typical Cash Retail | |---|---|---|---|---|---| | Metformin HCl | 500 mg | 90 tabs | ~$6 | ~$10 | ~$25 | | Imatinib | 400 mg | 30 tabs | ~$17 | ~$100 | ~$9,600+ | | Rosuvastatin | 10 mg | 90 tabs | ~$15 | ~$20 | ~$80 | | Lisinopril | 10 mg | 90 tabs | ~$5 | ~$7 | ~$20 | | Dasatinib | 50 mg | 60 tabs | ~$107 | ~$5,000+ | ~$25,000+ | | Levothyroxine | 50 mcg | 90 tabs | ~$7 | ~$9 | ~$25 |

When the Savings Are Largest

Savings are largest for off-patent branded drugs recently converted to generic form, particularly oncology medications. Imatinib (generic Gleevec) and dasatinib (generic Sprycel) show the most dramatic price gaps because their brand counterparts carry enormous list prices. The FDA's approval of multiple generic entrants for these drugs means manufacturer acquisition cost has dropped sharply, and Cost Plus Drugs passes that cost reduction directly to patients. [8]

When the Savings Are Modest or Zero

For ultra-low-cost generics already priced below $10 at warehouse clubs like Costco or Sam's Club, Cost Plus Drugs may offer little additional savings after the $5 shipping fee. A 90-count bottle of generic metformin 500 mg at Costco pharmacy runs approximately $4 to $7 without any discount program. If you add $5 shipping, Cost Plus Drugs may not beat that price on the smallest, cheapest fills.

The $3 Dispensing Fee and $5 Shipping

These two fixed costs matter more on small, cheap prescriptions than on expensive ones. On a $6 drug, the $8 in fixed fees adds 133% to the base cost. On a $107 drug, the $8 represents less than 8% overhead. Patients with multiple high-cost generics bundled into one order benefit most from the flat-rate shipping model.

Cost Plus Drugs vs. Alternatives: A Direct Comparison

Understanding where Cost Plus Drugs fits requires comparing it directly against GoodRx, traditional insurance co-pays, and other transparent-pricing pharmacies.

Cost Plus Drugs vs. GoodRx

GoodRx is a discount card and price-comparison platform, not a pharmacy. GoodRx negotiates group purchasing discounts through PBMs and passes a portion of those savings to consumers via coupons. A 2020 analysis in the Annals of Internal Medicine found GoodRx prices were lower than Medicare Part D cost-sharing for 23 of 40 common generics studied. [9]

Cost Plus Drugs eliminates the PBM layer entirely. For drugs on its formulary, Cost Plus Drugs prices are frequently lower than GoodRx coupons. However, GoodRx works at over 70,000 retail pharmacy locations nationwide, including chains that offer same-day pickup. Cost Plus Drugs requires 5 to 7 days for mail delivery. That gap matters for acute infections, short-course antibiotics, or patients without a 7-day supply buffer.

Cost Plus Drugs vs. Traditional Insurance

For patients with strong insurance plans with low co-pays, the comparison depends entirely on their specific formulary tier placements. A tier-1 generic with a $5 co-pay costs less than the Cost Plus Drugs price plus shipping on most cheap generics. But for drugs placed on tier 3 or tier 4, or for patients in the Medicare Part D coverage gap (the "donut hole"), cash-pay through Cost Plus Drugs may be cheaper. [10]

The Centers for Medicare and Medicaid Services reports that approximately 25% of Medicare beneficiaries reach the coverage gap each year. [10] For those patients, a transparent cash-pay option on high-cost generics represents real financial relief.

Cost Plus Drugs vs. Amazon Pharmacy and Walmart Health

Amazon Pharmacy offers RxPass at $5 per month for Prime members, covering roughly 50 generic medications. That model beats Cost Plus Drugs on price for patients who need multiple drugs already on the RxPass list. Walmart Health (prior to its 2024 closure) offered a $4/$10 generic list at retail locations with same-day pickup. The Walmart model prioritized convenience; Cost Plus Drugs prioritizes price breadth.

The FDA's current list of approved generic drugs includes over 10,000 products. [8] No single alternative covers that entire space at minimum markup. Patients benefit from checking multiple platforms before filling any expensive generic.

Specialty Drugs and Biologics: A Hard Limit

Cost Plus Drugs does not carry specialty biologics, injectables requiring cold chain, or REMS-restricted drugs as of early 2025. This is a firm limit of the model. Patients on GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound), or on biologic DMARDs for rheumatoid arthritis, will not find those products at Cost Plus Drugs. The FDA's REMS program covers over 60 drug programs with enhanced safety requirements that add regulatory complexity incompatible with simple mail-order fulfillment. [11]

Low-Margin Generics: The Business Model Explained

The Cost Plus Drugs business model rests on three structural pillars: direct manufacturer contracts, a fixed-margin pricing rule, and mail-order-only dispensing that eliminates retail overhead.

Direct Manufacturer Sourcing

By contracting directly with generic manufacturers, Cost Plus Drugs bypasses the traditional wholesale distribution chain, which typically adds 3% to 6% on top of manufacturer prices according to ASHP (American Society of Health-System Pharmacists) supply chain analyses. [12] For a drug priced at $1,000 at manufacturer level, that layer adds $30 to $60 before the pharmacy even applies its own markup.

The 15% Fixed Margin

Traditional retail pharmacy gross margins on generics have historically ranged from 20% to over 300% depending on the drug, the payer, and the contract, according to a 2020 report from the HHS Office of Inspector General. [13] A fixed 15% cap, publicly posted and not negotiable, removes the pharmacy's ability to extract higher margins on blockbuster generics where market power might otherwise allow it.

The American Journal of Managed Care published a 2022 analysis noting that PBM spread pricing for generics averaged $9.80 per prescription above the ingredient cost, a figure that disappears entirely in the Cost Plus model. [14]

Mail-Order Overhead Advantages

Retail pharmacies carry significant fixed costs: leased floor space, pharmacy counter staffing, retail shrinkage, and the overhead of managing insurance billing across dozens of payers. Mail-order operations consolidate dispensing volume in centralized fulfillment centers. The FDA has consistently found that mail-order pharmacies achieve lower dispensing costs per prescription than retail, with centralized verification processes that may also reduce dispensing error rates. [2]

A 2021 NEJM Perspective noted that the U.S. Drug pricing system's complexity partly arises from multi-layer intermediaries each adding margin. [15] The Cost Plus model is a direct response to that analysis.

Who Should and Should Not Use Cost Plus Drugs?

Patients Who Benefit Most

Uninsured adults represent approximately 25.6 million people in the United States as of 2023 per CDC estimates. [16] For this group, Cost Plus Drugs pricing on common chronic disease drugs (metformin, statins, ACE inhibitors, levothyroxine) is often the lowest available option after checking all platforms.

Underinsured patients with high-deductible health plans (HDHPs), which covered 54% of private-sector workers in firms with 200+ employees as of 2022 according to the Kaiser Family Foundation, frequently pay full retail prices until meeting their deductible. [17] For that group, Cost Plus Drugs pricing on expensive generics can save hundreds of dollars annually.

Patients on long-term oral oncology generics (imatinib, dasatinib, erlotinib, nilotinib) stand to save the most in absolute dollar terms.

Patients for Whom Cost Plus Drugs Is a Poor Fit

Patients who need controlled substances (Schedule II through IV) cannot use Cost Plus Drugs at all. Patients who need same-day dispensing for acute conditions, patients requiring specialty biologics, and patients whose insurance co-pays are already below the Cost Plus price after adding the $5 shipping fee should use alternative channels.

Elderly patients with limited internet access or difficulty navigating mail-order pharmacy workflows may find the process burdensome. The platform has no phone-based ordering option as of early 2025.

Cost Plus Drugs Reviews: What Real Patients Report

Published consumer reviews on independent platforms including Trustpilot and Consumer Affairs cluster around two themes: genuine surprise at the low prices for expensive generics, and frustration with prescription transfer delays or out-of-stock items.

The out-of-stock issue reflects a real supply chain constraint. Generic drug shortages are a documented problem across U.S. Pharmacy. The FDA's drug shortage database listed 128 active shortages as of late 2024, many involving generics in high demand. [18] A lean, direct-sourcing model like Cost Plus Drugs may be more vulnerable to spot shortages than larger wholesaler-backed retailers with diversified supplier contracts.

One frequently cited point in positive reviews is the transparency of the pricing page itself. The public listing of manufacturer acquisition cost alongside the final price is unusual in U.S. Pharmacy and earns consistent trust signals from pharmacist commentators. A 2022 editorial in the New England Journal of Medicine described the Cost Plus model as "the most concrete attempt yet to apply genuine price transparency to generic dispensing," citing its public acquisition-cost disclosure as a structural shift. [15]

Patient reviews also note that refill management is easier for maintenance medications than for acute or variable-dose prescriptions. Patients on stable doses of levothyroxine or lisinopril for years report a smooth refill experience. Patients whose doses change frequently, or who need mid-cycle medication changes, report friction in updating prescriptions through the mail-order pipeline.

Clinical Considerations for Providers Prescribing to Cost Plus Drugs Patients

Providers writing prescriptions for patients using Cost Plus Drugs should verify three things before sending an electronic prescription: the drug is on the formulary, the patient has a 7-day or longer supply buffer before the current supply runs out, and the dose and formulation listed on costplusdrugs.com matches what the provider intends to prescribe.

The FDA's guidance on bioequivalence for generic drugs requires that approved generics fall within an 80% to 125% confidence interval for the primary pharmacokinetic parameters of the reference listed drug. [19] All generics dispensed by Cost Plus Drugs carry standard FDA generic approval, meaning bioequivalence has been demonstrated to the same standard as any other pharmacy's generic supply.

Providers managing thyroid replacement therapy should note that the FDA and American Thyroid Association advise against switching between different manufacturers' levothyroxine formulations without re-checking TSH levels, because small formulation differences may cause clinical variability even within the approved bioequivalence range. [20] If a patient switches their levothyroxine source to Cost Plus Drugs, a TSH check at 6 to 8 weeks post-switch is appropriate standard of care.